Compare Rigetti Computing Inc (RGTI) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rigetti Computing Inc vs Tenet Healthcare Corporation — how do they compare? Rigetti Computing Inc trades at $14.03 (market cap $4.72B), while Tenet Healthcare Corporation trades at $263.78 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 4.4× Rigetti Computing Inc's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Rigetti Computing Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rigetti Computing Inc for 35 Days and Tenet Healthcare Corporation for 15 Days on average.
| RGTI | THC | |
|---|---|---|
Market Cap | $4.72B | $20.98B |
Volume | 17,136,381 | 428,008 |
Sector | Technology | Health |
52-Week High | $56.34 | $280.77 |
52-Week Low | $12.90 | $161.37 |
Typical Hold Time | 35 Days | 15 Days |
Enterprise Value | $4.33B | $32.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGTI trades at $14.03, down 3.84% with bearish technical signals despite bullish oscillators. The company shows minimal revenue of $7.09M (2025) with significant losses (-$216.21M net income) and negative margins. Analyst consensus remains strong with 85.71% buy ratings and $21.67 price target, while recent news highlights quantum computing sector momentum and Rigetti's hybrid quantum-HPC partnerships.
RGTI presents high-risk speculative potential with Wall Street optimism contrasting weak fundamentals. The stock offers substantial upside to analyst targets but faces execution risks in commercializing quantum technology amid persistent cash burn and competitive pressures from better-funded peers.
Tenet Healthcare (THC) trades at $263.78, up 1.52% today, with a bullish technical signal from moving averages and strong fundamental support. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 29, 2026. Revenue grew to $21.31B in 2025, with a robust net income margin of 9.9% and high return on equity of 53.31%, while valuation ratios like P/E of 10.07 and EV/EBITDA of 5.75 suggest potential undervaluation.
The outlook is positive, driven by earnings momentum and analyst consensus favoring buys, with a price target of $283.36 offering upside. Risks include reliance on surgical volumes and capital return sustainability, but strong cash flow and efficiency gains support growth. Investors should weigh solid fundamentals against sector-specific headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Rigetti Computing Inc
Rigetti Computing, Inc. is a pioneer in quantum computing, focusing on developing and deploying quantum-classical computing systems. The company designs and fabricates superconducting quantum processors and integrates them with a full-stack software and control platform. Rigetti offers access to its quantum computers through the cloud, aiming to solve complex computational problems that are intractable for classical computers, with applications in finance, chemistry, and machine learning.
Read more on RGTI →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
